'Garbage' Counterclaims Claim Nixed In Androgel IP Case
A Delaware federal judge has thrown out generics maker Perrigo Co.'s counterclaims alleging that AbbVie Inc. patents for the testosterone replacement gel Androgel are unenforceable due to inequitable conduct, calling the...To view the full article, register now.
Already a subscriber? Click here to view full article